During a live event, Matthew Lunning, DO, discussed key factors that determine whether patients should receive CAR T-cell ...
Erika Mayer, MD, MPH, Dana-Farber Cancer Institute, discusses the exciting findings of the phase 3 lidERA study investigating ...
Sacituzumab govitecan shows improved survival and quality of life in advanced triple-negative breast cancer, outperforming ...
According to Ira Zackon, MD, a hematologist-oncologist and senior medical director at Ontada, a retrospective study of over ...
Are you ready to practice medicine on your own terms but feel overwhelmed by the business side of independence? You’re not ...
A study reveals the gut microbiome's role in predicting multiple myeloma outcomes, highlighting butyrate-producing bacteria ...
The FDA's fast track designation acknowledges the combination's promising early efficacy and safety profile in treating MSS mCRC. Early data from a phase 1b/2 study showed deep, durable responses with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback